View in EDS

Efficacy and Tolerability of Zenocutuzumab in Advanced NRG1 Fusion-Positive Cholangiocarcinoma: Results From the eNRGy Phase II Trial.

Saved in:
Bibliographic Details
Title: Efficacy and Tolerability of Zenocutuzumab in Advanced NRG1 Fusion-Positive Cholangiocarcinoma: Results From the eNRGy Phase II Trial.
Authors: Cleary JM; Dana-Farber Cancer Institute, Boston, MA., Springfeld C; Heidelberg University Hospital, Heidelberg, Germany., Arnold D; Asklepios Klinik Altona, Hamburg, Germany., Hollebecque A; Gustave Roussy, Villejuif, France., Gbolahan O; Emory Winship Cancer Institute, Atlanta, GA., Nagasaka M; University of California Irvine School of Medicine, Orange, CA., Siena S; Department of Hematology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy.; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Opdam F; Netherlands Cancer Institute, Amsterdam, The Netherlands., Sunakawa Y; St Marianna University Hospital, Kawasaki, Japan., Cassier PA; Centre Léon Bérard, Lyon, France., Trikha G; Cancer Specialists of North Florida, Jacksonville, FL., Gort EH; Universitair Medisch Centrum Utrecht, Utrecht, The Netherlands., Florou V; Huntsman Cancer Institute, Salt Lake City, UT., Greil R; Salzburg Cancer Research Institute-Center for Clinical Cancer and Immunology Trials, Salzburg, Austria.; Paracelsus Medical University, Salzburg, Austria., La Porte PF; The Oncology Institute of Hope and Innovation-Long Beach, Cerritos, CA., Gandhi PJ; Partner Therapeutics, Inc, Lexington, MA., Garner F; Partner Therapeutics, Inc, Lexington, MA., Wasserman E; Merus, Cambridge, MA., Adeyemi S; Merus, Cambridge, MA., Schram AM; Memorial Sloan Kettering Cancer Center, New York, NY.
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2026 Jul 01, pp. JCO2503128. Date of Electronic Publication: 2026 Jul 01.
Publication Type: Journal Article
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42385125
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy and Tolerability of Zenocutuzumab in Advanced NRG1 Fusion-Positive Cholangiocarcinoma: Results From the eNRGy Phase II Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Cleary+JM%22">Cleary JM</searchLink>; Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Springfeld+C%22">Springfeld C</searchLink>; Heidelberg University Hospital, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Arnold+D%22">Arnold D</searchLink>; Asklepios Klinik Altona, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Hollebecque+A%22">Hollebecque A</searchLink>; Gustave Roussy, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Gbolahan+O%22">Gbolahan O</searchLink>; Emory Winship Cancer Institute, Atlanta, GA.<br /><searchLink fieldCode="AU" term="%22Nagasaka+M%22">Nagasaka M</searchLink>; University of California Irvine School of Medicine, Orange, CA.<br /><searchLink fieldCode="AU" term="%22Siena+S%22">Siena S</searchLink>; Department of Hematology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy.; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Opdam+F%22">Opdam F</searchLink>; Netherlands Cancer Institute, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Sunakawa+Y%22">Sunakawa Y</searchLink>; St Marianna University Hospital, Kawasaki, Japan.<br /><searchLink fieldCode="AU" term="%22Cassier+PA%22">Cassier PA</searchLink>; Centre Léon Bérard, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Trikha+G%22">Trikha G</searchLink>; Cancer Specialists of North Florida, Jacksonville, FL.<br /><searchLink fieldCode="AU" term="%22Gort+EH%22">Gort EH</searchLink>; Universitair Medisch Centrum Utrecht, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Florou+V%22">Florou V</searchLink>; Huntsman Cancer Institute, Salt Lake City, UT.<br /><searchLink fieldCode="AU" term="%22Greil+R%22">Greil R</searchLink>; Salzburg Cancer Research Institute-Center for Clinical Cancer and Immunology Trials, Salzburg, Austria.; Paracelsus Medical University, Salzburg, Austria.<br /><searchLink fieldCode="AU" term="%22La+Porte+PF%22">La Porte PF</searchLink>; The Oncology Institute of Hope and Innovation-Long Beach, Cerritos, CA.<br /><searchLink fieldCode="AU" term="%22Gandhi+PJ%22">Gandhi PJ</searchLink>; Partner Therapeutics, Inc, Lexington, MA.<br /><searchLink fieldCode="AU" term="%22Garner+F%22">Garner F</searchLink>; Partner Therapeutics, Inc, Lexington, MA.<br /><searchLink fieldCode="AU" term="%22Wasserman+E%22">Wasserman E</searchLink>; Merus, Cambridge, MA.<br /><searchLink fieldCode="AU" term="%22Adeyemi+S%22">Adeyemi S</searchLink>; Merus, Cambridge, MA.<br /><searchLink fieldCode="AU" term="%22Schram+AM%22">Schram AM</searchLink>; Memorial Sloan Kettering Cancer Center, New York, NY.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228309333%22">Journal of clinical oncology : official journal of the American Society of Clinical Oncology</searchLink> [J Clin Oncol] 2026 Jul 01, pp. JCO2503128. <i>Date of Electronic Publication: </i>2026 Jul 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Clinical+Oncology%22">American Society of Clinical Oncology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8309333 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1527-7755 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220732183X%22">0732183X </searchLink><i>NLM ISO Abbreviation: </i>J Clin Oncol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42385125
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1200/JCO-25-03128
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: JCO2503128
    Titles:
      – TitleFull: Efficacy and Tolerability of Zenocutuzumab in Advanced NRG1 Fusion-Positive Cholangiocarcinoma: Results From the eNRGy Phase II Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Cleary JM
      – PersonEntity:
          Name:
            NameFull: Springfeld C
      – PersonEntity:
          Name:
            NameFull: Arnold D
      – PersonEntity:
          Name:
            NameFull: Hollebecque A
      – PersonEntity:
          Name:
            NameFull: Gbolahan O
      – PersonEntity:
          Name:
            NameFull: Nagasaka M
      – PersonEntity:
          Name:
            NameFull: Siena S
      – PersonEntity:
          Name:
            NameFull: Opdam F
      – PersonEntity:
          Name:
            NameFull: Sunakawa Y
      – PersonEntity:
          Name:
            NameFull: Cassier PA
      – PersonEntity:
          Name:
            NameFull: Trikha G
      – PersonEntity:
          Name:
            NameFull: Gort EH
      – PersonEntity:
          Name:
            NameFull: Florou V
      – PersonEntity:
          Name:
            NameFull: Greil R
      – PersonEntity:
          Name:
            NameFull: La Porte PF
      – PersonEntity:
          Name:
            NameFull: Gandhi PJ
      – PersonEntity:
          Name:
            NameFull: Garner F
      – PersonEntity:
          Name:
            NameFull: Wasserman E
      – PersonEntity:
          Name:
            NameFull: Adeyemi S
      – PersonEntity:
          Name:
            NameFull: Schram AM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2026 Jul 01
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1527-7755
          Titles:
            – TitleFull: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
              Type: main
ResultId 1